静脉注射麻醉剂对人类通道有不同的影响
Ying Tao1,2, Kejie Yao3, Jing Wu4
1Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Acta biochimica et biophysica Sinica
|May 19, 2025
概括
普罗波福和胺等全身麻醉剂会影响特定的通道 (TASK-3,SK1,SK3),这可能解释心血管和呼吸系统的副作用. 这项研究确定了麻醉剂与这些重要离子通道之间的关键相互作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
- 麻醉学 麻醉学
背景情况:
- 整体麻醉在手术中至关重要,但会导致严重的心血管和呼吸道并发症.
- 这些麻醉诱导的副作用背后的精确机制尚未完全理解.
- 通道在心血管和呼吸系统调节中起着至关重要的作用,但它们与麻醉剂的直接相互作用尚不清楚.
研究的目的:
- 研究常见的静脉通用麻醉剂 (propofol,pentobarbital,ketamine) 对特定通道的直接作用.
- 为了确定这些麻醉剂和关键通道亚型之间的分子相互作用.
- 阐明通道在麻醉引起的生理并发症中的潜在作用.
主要方法:
- 在Xenopus卵细胞中表达TASK-1,TASK-3,Kv1.5,Kv2.1,Kir2.1,SK1和SK3通道.
- 对麻醉剂对通道电流的影响的电生理学评估.
- 同质模型和分子对接模拟用于预测药物道相互作用.
主要成果:
- 醇增强了TASK-3电流,而胺增强了SK3电流.
- 胺抑制了SK1电流,而巴比他也抑制了SK1电流.
- 分子对接确定了特定的残留物相互作用:propofol与TASK-3 Q126,ketamine与SK1 S290和SK3 S467,以及pentobarbital与SK1 S330/T358.
结论:
- 静脉麻醉剂直接调节特定通道的功能,包括TASK-3,SK1和SK3.
- 已识别的分子相互作用为了解麻醉剂如何影响通道活动提供了基础.
- 这些发现为与全身麻醉相关的呼吸和循环系统副作用的机制提供了新的见解.
相关概念视频
Parenteral Anesthetics: Overview
91
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
91
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
879
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
879
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K
Local Anesthetics: Pharmacokinetics
716
The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...
716
Local Anesthetics: Adverse Effects
385
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
385
Voltage-gated Ion Channels
7.9K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
7.9K


